Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

5.47
Delayed Data
As of 1:19pm ET
 +0.13 / +2.43%
Today’s Change
4.27
Today|||52-Week Range
9.50
-12.90%
Year-to-Date

Today’s Trading

Previous close5.34
Today’s open5.42
Day’s range5.18 - 5.53
Volume29,374
Average volume (3 months)163,115
Market cap$146.1M
Dividend yield--
Data as of 1:19pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)+59.44%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.67

Competitors

 Today’s
change
Today’s
% change
--China Health Group I...+0.02+11.87%
ACRXAcelRx Pharmaceutica...+0.13+3.92%
LPCNLipocine Inc+0.33+4.05%
CPRXCatalyst Pharmaceuti...+0.02+1.16%
Data as of 1:40pm ET, 02/12/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$32.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers